| Irritable bowel syndrome and small intestinal bacterial overgrowth. | |
| | |
MedLine Citation:
|
PMID: 20838236 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In the last 3 decades, there has been a growing appreciation for the role of gut bacteria in gastrointestinal disease. Although inflammatory bowel disease and peptic ulcer disease have established a role for gut bacteria for more than 20 years, there is now increasing evidence that intestinal bacteria may play a role in irritable bowel syndrome as well. In this review, the current evidence for bacteria in irritable bowel syndrome will be examined. |
| | |
Authors:
|
David Yamini; Mark Pimentel |
Related Documents
:
|
8903566 - Therapy of sphincter of oddi dysfunction. 14653836 - Current patterns of irritable bowel syndrome in taiwan: the rome ii questionnaire on a ... 21879016 - Antiphospholipid syndrome in childhood systemic lupus erythematosus. 8776016 - Guillain-barré syndrome in children. 10564866 - Accumulation of irrigation fluid in the calf as a complication during high tibial osteo... 18300386 - Drug-associated histiocytoid sweet's syndrome: a true neutrophilic maturation arrest va... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Journal of clinical gastroenterology Volume: 44 ISSN: 1539-2031 ISO Abbreviation: J. Clin. Gastroenterol. Publication Date: 2010 Nov-Dec |
Date Detail:
|
Created Date: 2010-10-18 Completed Date: 2011-02-01 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7910017 Medline TA: J Clin Gastroenterol Country: United States |
Other Details:
|
Languages: eng Pagination: 672-5 Citation Subset: IM |
Affiliation:
|
GI Motility Program, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-Bacterial Agents
/
therapeutic use Evidence-Based Medicine Gastrointestinal Agents / therapeutic use Humans Intestine, Small / drug effects, microbiology* Irritable Bowel Syndrome / diagnosis, drug therapy, microbiology* Risk Assessment Risk Factors Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Bacterial Agents; 0/Gastrointestinal Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Outcomes of Treatment of Argon Plasma Coagulation Therapy in Elderly or High-risk Patients With Earl...
Next Document: A multidisciplinary therapeutic approach for reducing the risk of psychiatric side effects in patien...